Latest Drug Approvals news
FDA Approves Bimzelx for Three New Indications
posted September 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Injectable Ocrevus Zunovo for Relapsing, Progressive MS
posted September 26th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis
posted September 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Healthy Lifestyle in Early Childhood Linked to Lower Risk for IBD .jpeg)
Most Adults With Moderate-to-Severe Ulcerative Colitis Ineligible for RCTs 
Emergency Diagnosis Linked to Worse Outcomes for Range of Conditions 
Bowel Urgency in Ulcerative Colitis Linked to Disease-Related Disability Related Articles
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
